Guerbet lands FDA nod for contrast injector

AuntMinnie.com staff writers
Feb 10, 2016

Contrast agent manufacturer Guerbet has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OptiOne single-head CT contrast delivery system.

An entry-level, single-head injector, OptiOne debuted in Europe in 2015 and is available in ceiling-suspended and pedestal configurations, according to the firm. It includes a programmable powerhead and can accommodate prefilled or empty syringes, Guerbet said.

OptiOne is manufactured by Liebel-Flarsheim, which was acquired by Guerbet as part of its acquisition of Mallinckrodt's Contrast Media and Delivery Systems business in November.

Latest in CT
Lung Cancer
Novel risk prediction model improves LCS uptake
April 23, 2024
Doctor Female Young Desk 400
Radiologist consultation improves patients' LCS attitudes
April 18, 2024
Lung cancer screening that meets your patients’ needs
Sponsored
Lung cancer screening that meets your patients’ needs
April 2, 2024
Ai
CT-based deep learning identifies patients at further lung cancer risk
April 16, 2024
Related Stories
2015 02 27 13 00 49 203 Hands Shaking V2 200
MRI
Guerbet sees Mallinckrodt deal as key to growth
2016 02 10 15 07 28 25 Thumbsupanddown2 200
CT
Radiologists prefer optical colonoscopy over CTC
2015 10 19 17 01 40 918 No Smoking 200
CT
Smokers ineligible for screening have same lung cancer rate
You think ahead. We innovate ahead.
Sponsor Content
You think ahead. We innovate ahead.
More in CT
Novel risk prediction model improves LCS uptake
By Kate Madden Yee
A novel risk prediction model used in the Ontario Lung Cancer Screening Pilot increased the uptake of lung cancer screening among eligible Canadians, researchers have found.
April 23, 2024
Lung Cancer
Radiologist consultation improves patients' LCS attitudes
By Kate Madden Yee
Consulting with a radiologist boosts patients' attitudes toward lung cancer screening (LCS) and their interest in quitting smoking, researchers have reported.
April 18, 2024
Doctor Female Young Desk 400
Tailored lung cancer screening model helps determine nodule follow-up
By Kate Madden Yee
A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT helps clinicians determine how to follow up better than rule-based protocols, researchers have found.
April 17, 2024
Lung Cancer
CT-based deep learning identifies patients at further lung cancer risk
By Kate Madden Yee
A CT-based deep learning model can identify individuals with clinical stage IA non-small cell lung cancer (NSCLC) at high risk of further disease, researchers have found.
April 16, 2024
Ai
CT-FFR reduces invasive procedures for coronary artery blockages
By Kate Madden Yee
CT fractional flow reserve (CT-FFR) imaging identifies patients with coronary artery blockage or narrowing who could benefit from revascularization -- and helps reduce the unnecessary use of invasive procedures, researchers have found.
April 11, 2024
Heart Pulmonary Trunk
Experts say consider BMI when imaging patients with chest pain
By Will Morton
A patient’s body mass index (BMI) has a significant effect on how much radiation exposure they receive from chest imaging in cases of suspected cardiac ischemia.
April 11, 2024
Heart Attack
AI model predicts invasiveness of lung cancer on CT scans
By Will Morton
Radiologists in Beijing, China, have developed a joint deep-learning and radiomics AI model that can flag how invasive tumors may be in patients with lung cancer.
April 9, 2024
Lung Ai
Is CTA overused in the emergency department?
By Amerigo Allegretto
CT angiography (CTA) may be overused in the emergency department, new research suggests.
April 1, 2024
Patient Elderly Confused Headache 400
Deep learning helps distinguish benign vertebral fractures on CT
By Kate Madden Yee
A deep-learning algorithm used with CT imaging can differentiate between benign and malignant vertebral fractures, researchers have found.
March 27, 2024
Overview of the automated deep learning-based pipeline. Multidetector CT images show the (A) original data, (B, C) vertebral segmentation, and (D-F) vertebral labeling during preprocessing. Images and caption courtesy of the RSNA.
The rise of theranostics: Part 1 -- Gaining momentum
By Liz Carey
FDA-approved radiopharmaceuticals have energized the field of theranostics. In part 1 of a series, experienced theranostics leaders offer implications of the latest clinical trials, how a theranostics clinic works, and advice for introducing theranostics.
March 26, 2024
Team members from the theranostics clinic under University of Texas Health Science Center at San Antonio's Department of Radiology show one aspect of a Pluvicto infusion treatment. The L block lead shield over the syringe helps protect certified nuclear medicine technologist James Johnson (left), and nuclear radiologist Penny Vroman, MD (right), from radiation emitted by the drug. (Photo courtesy of UT Health San Antonio Department of Radiology)
CT shows effects of sarcopenia on liver cancer survival
By Kate Madden Yee
CT has revealed that sarcopenia is a prognostic factor for poor overall survival after liver resection for cancer, researchers have reported.
March 22, 2024
Liver Cancer
Training technique in AI helps preserve patient privacy
By Will Morton
The privacy of patient data in AI models trained on chest x-rays can be guaranteed – importantly, without significantly reducing the accuracy of models on large “real-world” data sets.
March 18, 2024
Ai Bias
Page 1 of 654
Next Page